Home Medicine Neither maternal nor fetal mutation (E474Q) in the α-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome
Article
Licensed
Unlicensed Requires Authentication

Neither maternal nor fetal mutation (E474Q) in the α-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome

  • Sabine Mütze , Ines Ahillen , Sabine Rudnik-Schoeneborn , Thomas Eggermann , Brigitte Leeners , Peruka M. Neumaier-Wagner , Sabine Kuse , Werner Rath and Klaus Zerres
Published/Copyright: February 1, 2007
Journal of Perinatal Medicine
From the journal Volume 35 Issue 1

Abstract

Objective: An association between maternal HELLP syndrome and fetal long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency has been proposed. LCHAD catalyzes the third step in the β-oxidation of fatty acids in mitochondria. Whereas about 75% of LCHAD-deficient patients carry a G-to-C mutation at nucleotide position 1528 (Glu474Gln, E474Q) on both chromosomes, compound heterozygosity for E474Q on one chromosome and a second different LCHAD mutation on the other can be observed in up to 25% of LCHAD-deficiency cases; only very few patients carry two mutations different from E474Q. Genetic analysis of the mother alone is insufficient in case of compound heterozygosity. Since information on the fetal carrier status of the E474Q mutation in maternal HELLP syndrome is rare, we investigated the frequency of the E474Q mutation in families where the mother had HELLP syndrome.

Methods: The occurrence of the E474Q mutation was analyzed by PCR and RFLP in 103 mothers with HELLP syndrome, in 82 children of affected pregnancies and in 21 fathers in families where fetal DNA was not available. In addition, 103 control women with only uncomplicated pregnancies were investigated.

Results: The mutation E474Q was not detected in the study population.

Conclusion: Neither maternal nor fetal heterozygosity for the E474Q mutation is a relevant factor of HELLP syndrome.

:

Corresponding author: Dr. Sabine Mütze, MD Universitätsklinikum der RWTH Institut für Humangenetik, Universitätsklinikum der RWTH Pauwelsstr. 30, D-52057 Aachen, Germany Tel.: +49-241-80-88107 Fax: +49-241-80-82580

References

[1] Blish KR, JA Ibdah: Maternal heterozygosity for a mitochondrial trifunctional protein mutation as a cause for liver disease in pregnancy. Med Hypotheses64 (2005) 96Search in Google Scholar

[2] den Boer ME, L IJlst, FA Wijburg, W Oostheim, MA van Werkhoven, MG van Pampus, HS Heymans, RJ Wanders: Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res48 (2000) 151Search in Google Scholar

[3] Ibdah JA, MJ Bennett, P Rinaldo, Y Zhao, B Gibson, HF Sims, AW Strauss: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med340 (1999) 1723Search in Google Scholar

[4] Ibdah JA, Z Yang, MJ Bennett: Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab71 (2000) 182Search in Google Scholar

[5] IJlst L, JP Ruiter, JM Hoovers, ME Jakobs, RJ Wanders: Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest98 (1996) 1028Search in Google Scholar

[6] Miller SA, DD Dykes, HF Polesky: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res16 (1988) 1215Search in Google Scholar

[7] Rath W, A Faridi, JW Dudenhausen: HELLP syndrome. J Perinat Med28 (2000) 249Search in Google Scholar

[8] Strauss AW, MJ Bennett, P Rinaldo, HF Sims, LK O'Brien, Y Zhao, B Gibson, JA Ibdah: Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol23 (1999) 100Search in Google Scholar

[9] Tyni T, E Ekholm, H Pihko: Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol178 (1998) 603Search in Google Scholar

[10] Uchida Y, K Izai, T Orii, T Hashimoto: Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem267 (1992) 1034Search in Google Scholar

[11] Yang Z, J Yamada, Y Zhao, AW Strauss, JA Ibdah: Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. J Am Med Assoc288 (2002) 2163Search in Google Scholar

Published Online: 2007-02-01
Published in Print: 2007-02-01

©2007 by Walter de Gruyter Berlin New York

Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2007.012/pdf
Scroll to top button